EVIO (EVIO) Institutional Ownership: 0.01% (As of Jul. 05, 2026)


What is EVIO Institutional Ownership?

EVIO EVIO -98.00% Institutional Ownership is 0.01% as of Jul. 05, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, EVIO's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, EVIO's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, EVIO's Float Percentage Of Total Shares Outstanding is 99.98%.

EVIO Institutional Ownership Historical Data

* Premium members only.

The historical data trend for EVIO's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVIO Institutional Ownership Chart

EVIO Historical Data

The historical data trend for EVIO can be seen below:

2018-09-30 2018-10-31 2018-11-30 2018-12-31 2019-01-31 2019-02-28 2019-03-31 2019-04-30 2019-05-31 2019-06-30
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01

EVIO Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.01% mean?
EVIO (EVIO) has a Institutional Ownership of 0.01% as of Jul. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on EVIO and its competitors.
Is EVIO's Institutional Ownership too high?
EVIO's current Institutional Ownership is 0.01%.
How does EVIO's Institutional Ownership compare to VCBD and ACCA?
EVIO's Institutional Ownership of 0.01% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on EVIO and its competitors. EVIO's current Institutional Ownership is 0.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVIO stock overvalued right now?
EVIO (EVIO) has a current Institutional Ownership of 0.01%. The current Institutional Ownership is 0.01%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For EVIO (EVIO), the current Institutional Ownership is 0.01% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EVIO Business Description

Address 2654 W. Horizon Ridge Drive Parkway, Suite B5-208, Henderson, NV, USA, 89052
EVIO Inc is a Colorado corporation and a diversified holding company. Its subsidiaries provide analytical testing and advisory services to the emerging legalized cannabis industry. The Company performs analytical testing for cannabis and cannabis-derived products, including hemp and CBD products. Its current operations also include pharmaceutical, environmental, stability, and analytical testing, as well as residential and commercial construction and investments, with operations in the United States and Canada.